Skip to main content

University of Missouri

News

New Research Offers Hope in Fight Against Blood Cancers

A groundbreaking process developed by researchers based in the Roy Blunt NextGen Precision Health Building is offering new hope in the fight against blood cancers, such as lymphoma and leukemia.

A new view of microscopic processes

New equipment for a specialized electron microscope at the University of Missouri is added with the support of a $800,000 grant from the National Science Foundation.

Research Finds Link Between Western Diets and Chronic Liver Disease

New research from the University of Missouri School of Medicine has established a link between western diets high in fat and sugar and the development of non-alcoholic fatty liver disease, the leading cause of chronic liver disease.

Regulating immunological memory may help immune system fight disease, MU study finds

Findings may help development of potential vaccines or immunotherapies for cancer and various inflammatory diseases.

Growth and discovery: NextGen marks one year

NextGen researchers have been awarded $97 million in grants in first year.

A chance at ‘upcycling’ life

A mid-Missouri woman benefits from the power of advancements in science and medicine harnessed at the University of Missouri and supported by MU’s most ambitious research initiative, the NextGen Precision Health initiative.

W. David Arnold named new executive director of NextGen Precision Health initiative

University of Missouri President Mun Choi and Richard J. Barohn, executive vice chancellor for health affairs and dean of the School of Medicine, have named W. David Arnold as the next executive director of the NextGen Precision Health initiative.

Learn more about MU’s Translational Biosciences PhD Program

The University of Missouri’s Translational Biosciences PhD program is innovating how scientists are trained, resulting in producing better outcomes for our community — a staple of the NextGen Precision Health initiative. Watch this video to learn more.

Drug that lowers blood sugar also reduces blood vessel dysfunction caused by aging

An FDA-approved drug medication intended to lower blood sugar may also prevent vascular constriction and stiffening in aging male mice.

Modifying the body’s immune system to help treat Type 1 diabetes

Scientists at University of Missouri collaborate with Harvard, Georgia Tech to develop a novel diabetes treatment involving transplanting pancreas cells that produce insulin.

Personalizing the fight against flu

With the opening of the NextGen Center for Influenza and Emerging Infectious Diseases, MU researcher Henry Wan is working toward a deeper understanding of the flu.

Comparative excellence

Mizzou 18 recipient and graduate researcher Ryan Dashek turned a love of animals into a passion for comparative medicine.

MU announces nearly $4 million MizzouForward investment in student success

President Choi also shares news of more than $60 million from federal government to support NextGen construction and faculty endowments

Talent magnet

World-class researchers and state-of-the art equipment make their way to NextGen.

To find the right cure

The new Roy Blunt NextGen Precision Health building is part of a larger precision health initiative.

NextGen researcher profile: Christian Lorson

The associate vice chancellor for research and strategic initiatives has found a logical extension from his previous research to a disease that affects several million people around the world.

Roy Blunt NextGen Precision Health Building Grand Opening

Photo gallery: Roy Blunt NextGen Precision Health Building Grand Opening

Researchers Receive $2.3 Million Grant to Weaponize Gut Bacteria Against Liver Cancer

A new MU research study will examine how bacteria can optimize immunotherapy treatments.

Fanfare for NextGen

Learn about Luis Hermano Bezerra, a University of Missouri graduate student whose original composition helped celebrate the grand opening of the Roy Blunt NextGen Precision Health building.

University of Missouri celebrates grand opening of the Roy Blunt NextGen Precision Health building

The building anchors the NextGen initiative, which will accelerate critical health care discoveries and treatments.

Discovery Series - Home